Importance of host sex in the development of trypanosoma cruzi infection
DOI:
https://doi.org/10.31053/1853.0605.v67.n2.23421Keywords:
Chagas disease, Trypanosoma cruzi, influence of the sex of the host, cardiomyopathyAbstract
Multiple factors, both dependent on the host and the parasite are involved in determining resistance or susceptibility to infection with T. cruzi, but the influence of the sex of the host is a factor that has not been clearly established.
In this paper we analyzed the influence of this factor upon the infected individuals. We used Swiss albino mice infected with 50 trypomastigotes / mouse of T. cruzi, strain Tulahuen: males (n = 73) and females (n = 64). The highest parasitemia was detected on day 21 post-infection (pi) in both males and females and became negative on day 56 pi, and males exhibited significantly higher levels of parasitemia (p <0.05). The highest mortality occurred between day 21 and day 28 pi; by day 270 pi (chronic stage) one male (3%) survived every 7.6 females (23%). In skeletal muscle of male and female mice on days 90, 180 and 270 pi, lympho-monocitary infiltrates were found nests of amastigotes, whereas the myocardium of these animals showed inflammatory infiltrates only. We conclude that males showed greater susceptibility to infection and higher mortality than females in this mouse model infected with T. cruzi, Tulahuen strain, but the characteristics of the infection and cardiomyopathy development are similar in nature.
Downloads
References
Rassi A, Tranchesi B. DoenÇa de Chagas. En: Veronesi A, Editor. DoenÇa Infecciosas Parasitarias. Rio de janeiro: Guanabara Koogan 1991. p. 674-705.
Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz. 2003, 98(5): 577-591.
Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV. Pathogenesis of Chronic Chagas heart disease. Circulation 2007, 115: 1109-1123.
Atías, A.; Neghme, A. Enfermedad de Chagas. Parasitología Clínica. 1991. Cap 30. Editorial Mediterránea 3ª Ed. 251-263.
Apt BW, Heitmann GI, Jercic LMI et al. Guías clínicas de la enfermedad de Chagas: Parte II. Enfermedad de Chagas en el adulto, la infancia y adolescencia. Rev Chil Infectol 2008, 25(3): 194-199.
Kierszenbaum F. Where do we stand on the autoimmunity hypothesis of Chagas disease? Trends Parasitol 2005, 21: 513-516.
Wrightsman R, Krassner S,Watson J. Genetic control of response to Trypanosoma cruzi in mice: Multiple genes influencing parasitemia and survival. Infect Inmun 1982, 36: 637-644.
Juri MA, Ferreira A, Ramos A et al. Non-lytic antibodies in H-2 controlled resistance to acute infection with Trypanosoma cruzi. Braz J Med Biol Res 1990, 23: 685-695.
Goble F C. Lack of effect of sex hormones on the course of experimental Chagas disease in mice. J Parasitol 1952, 78: 15-16.
Hauschka T. Sex of host as factor in Chagas disease. J Parasitol 1947, 33: 399-405.
López L, Arai K, Giménez E, Jiménez M, Pascuzo C, Rodríguez-Bonfante C, Bonfante-Cabarcas R. C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure. Rev Esp Cardiol 2006; 59(1): 50-56.
Basquiera AL, Sembaj A, Aguerri AM, Omelianiuk M, Guzmán S, Moreno Barral J, Caeiro TF, Madoery RJ, Salomone OA. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart 2003, 89: 1186-90.
London GM, Guerin AP, Pannier B, Marchais SJ, Stimpel M. Influence of sex on arteria hemodynamics and blood pressure role of body height. Hypertension 1995, 26: 514-519.
Roselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 bestradiol and norethisterona acetato: a two year follow-up study. Hypertension 1995, 25: 848-853.
Practico D, FitzGerald GA. Tetosterone and thromboxane: Of muscles, mice and men. Circulation 1995, 91: 2694-2698.
Downloads
Published
How to Cite
Issue
Section
License
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).
